EMAIL THIS PAGE TO A FRIEND

Journal of pharmaceutical sciences

Sucrose esters increase drug penetration, but do not inhibit p-glycoprotein in caco-2 intestinal epithelial cells.


PMID 25042090

Abstract

Sucrose fatty acid esters are increasingly used as excipients in pharmaceutical products, but few data are available on their toxicity profile, mode of action, and efficacy on intestinal epithelial models. Three water-soluble sucrose esters, palmitate (P-1695), myristate (M-1695), laurate (D-1216), and two reference absorption enhancers, Tween 80 and Cremophor RH40, were tested on Caco-2 cells. Caco-2 monolayers formed a good barrier as reflected by high transepithelial resistance and positive immunostaining for junctional proteins claudin-1, ZO-1, and β-catenin. Sucrose esters in nontoxic concentrations significantly reduced resistance and impedance, and increased permeability for atenolol, fluorescein, vinblastine, and rhodamine 123 in Caco-2 monolayers. No visible opening of the tight junctions was induced by sucrose esters assessed by immunohistochemistry and electron microscopy, but some alterations were seen in the structure of filamentous actin microfilaments. Sucrose esters fluidized the plasma membrane and enhanced the accumulation of efflux transporter ligands rhodamine 123 and calcein AM in epithelial cells, but did not inhibit the P-glycoprotein (P-gp)-mediated calcein AM accumulation in MES-SA/Dx5 cell line. These data indicate that in addition to their dissolution-increasing properties sucrose esters can enhance drug permeability through both the transcellular and paracellular routes without inhibiting P-gp.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB4200462
Anti-Claudin-1 antibody produced in rabbit, ~1.0 mg/mL, affinity isolated antibody
SAB1406776
Anti-CLDN1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
AV33623
Anti-CLDN1 antibody produced in rabbit, affinity isolated antibody
SAB3500438
Anti-CLDN1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2100443
Anti-CLDN7 (ab1) antibody produced in rabbit, affinity isolated antibody
SAB2100444
Anti-CLDN7 (ab2) antibody produced in rabbit, affinity isolated antibody
HPA014703
Anti-CLDN7 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
A5882
Antipyrine, analytical standard
C11H12N2O
10784
Antipyrine, tested according to Ph.Eur.
C11H12N2O
10790
Antipyrine, ≥99.0% (RT)
C11H12N2O
90567
Antipyrine, analytical reference material
C11H12N2O
74827
Atenolol, analytical reference material
C14H22N2O3
1044403
Atenolol, United States Pharmacopeia (USP) Reference Standard
C14H22N2O3
A1340000
Atenolol, European Pharmacopoeia (EP) Reference Standard
C14H22N2O3
39971
Benzyl alcohol, certified reference material, TraceCERT®
C7H8O
08421
Benzyl alcohol, analytical standard
C7H8O
1061901
Benzyl alcohol, United States Pharmacopeia (USP) Reference Standard
C7H8O
13162
Benzyl alcohol, tested according to Ph.Eur.
C7H8O
PHR1019
Benzyl alcohol, Pharmaceutical Secondary Standard; Certified Reference Material
C7H8O
Y0000167
Benzyl alcohol, European Pharmacopoeia (EP) Reference Standard
C7H8O
WH0009076M1
Monoclonal Anti-CLDN1 antibody produced in mouse, clone 1C5-D9, purified immunoglobulin, buffered aqueous solution
SAB1404666
Monoclonal Anti-CLDN1 antibody produced in mouse, clone 2E2-H5, purified immunoglobulin, buffered aqueous solution